Traciga 10/5 Milligrams (Dapagliflozin Propanediol Monohydrate, Linagliptin)

Adult dosage

This medication is administered at a dose of 1 tablet containing 10 mg of dapagliflozin and 5 mg of linagliptin once daily, regardless of meals.

This medication should not be used in patients who have had allergic reactions to the active ingredients or excipients. It should not be administered to patients with Type 1 diabetes, diabetic ketoacidosis, those undergoing dialysis, or those with a history of myocardial infarction. Caution is necessary in patients with reduced fluid volume or impaired kidney function due to the risk of hypotension or kidney damage. When used with blood sugar-lowering medications, the risk of hypoglycemia may increase, so dose adjustments may be necessary. It should be used with caution in patients with heart failure and is not recommended for severe heart failure patients. If acute pancreatitis symptoms develop, the medication should be discontinued immediately and a physician consulted. If vesicular skin diseases occur, discontinue the medication and seek specialist care. This medication may increase the risk of genital infections and urinary tract infections, requiring prompt treatment if symptoms arise. Elderly patients or those taking diuretics have a higher risk of fluid volume depletion and hypotension, so blood pressure and kidney function should be monitored regularly. Use is not recommended during pregnancy or breastfeeding, and it should be discontinued immediately if pregnancy is confirmed. Safety in children has not been established, so it is advisable not to use this medication in that population. There is no specific antidote for overdose; appropriate treatment should be carried out based on symptoms. It is important to regularly check blood sugar control, kidney function, and blood pressure during the use of this medication. If discomfort or adverse reactions occur during medication use, immediate consultation with healthcare professionals is necessary.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory issues with cough + fever, jaundice (yellowing of skin or eyes), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Constipation
• diarrhea
• dizziness
• palpitations
• weight loss
• vulvar pruritus
• sweating
• cystitis
• urinary tract infections
• thirst

This medication should be stored in a tightly sealed container to prevent exposure to air and light, at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the efficacy of the medication and prevent deterioration.

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box [7 tablets/PTP × 4], 30 tablets/bottle